Association between Gut Microbiota Profiles, Dietary Intake, and Inflammatory Markers in Overweight and Obese Women
Author:
Chansa Orada1, Shantavasinkul Prapimporn Chattranukulchai2ORCID, Monsuwan Wutarak3, Sirivarasai Jintana3ORCID
Affiliation:
1. Master of Science Program in Nutrition, Faculty of Medicine Ramathibodi Hospital, Institute of Nutrition, Mahidol University, Bangkok 10400, Thailand 2. Division of Nutrition and Biochemical Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand 3. Nutrition Unit, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
Abstract
Being overweight and obesity are significant global public health challenges due to their association with adipose tissue dysfunction, pro-inflammatory marker production, and alterations in gut microbiota composition. To explore the relationship between gut microbiota, dietary factors, and inflammatory markers in overweight or obese women, we conducted a cross-sectional study involving a healthy group (n = 20) and an overweight or obese group (n = 75). We collected data, including clinical, anthropometric, and dietary assessments, and carried out a blood biochemical analysis, the measurement of inflammatory biomarkers (hs-CRP, IL-6, and TNF-α), and the 16S rRNA gene sequencing of fecal samples. The gut microbiota analysis revealed notable differences in alpha and beta diversity between the two groups. Moreover, the abundance of gut microbiota in the overweight or obese group correlated positively with adiposity markers, blood pressure, lipid profiles, and inflammatory markers. These findings highlight significant changes in gut microbiota associated with obesity, potentially implicating pathways such as lipopolysaccharide biosynthesis. Understanding the role of the gut microbiome in obesity could reveal specific avenues for intervention.
Funder
Mahidol University
Reference48 articles.
1. Yang, M., Liu, S., and Zhang, C. (2022). The related metabolic diseases and treatments of obesity. Healthcare, 10. 2. Lin, X., and Li, H. (2021). Obesity: Epidemiology, pathophysiology, and therapeutics. Front. Endocrinol., 12. 3. The gut microbiome: A core regulator of metabolism;Fujisaka;J. Endocrinol.,2023 4. Candelli, M., Franza, L., Pignataro, G., Ojetti, V., Covino, M., Piccioni, A., Gasbarrini, A., and Franceschi, F. (2021). Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases. Int. J. Mol. Sci., 22. 5. Mohammad, S., and Thiemermann, C. (2021). Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front. Immunol., 11.
|
|